We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHardide Regulatory News (HDD)

Share Price Information for Hardide (HDD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.25
Bid: 6.00
Ask: 6.50
Change: 0.00 (0.00%)
Spread: 0.50 (8.333%)
Open: 6.25
High: 6.25
Low: 6.25
Prev. Close: 6.25
HDD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

17 May 2023 07:00

RNS Number : 6246Z
Hardide PLC
17 May 2023
 

The information communicated in this announcement is inside information for the purposes of Article 7 of the Market Abuse Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR").

 

 

17 May 2023

 

Hardide plc

("Hardide, the "Group" or the "Company")

 

Interim Results for the six months ended 31 March 2023

 

EBITDA breakeven performance driven by continuing revenue growth and improving gross margin

 

Hardide plc (AIM: HDD), the developer and provider of advanced surface coating technology, announces its results for the six-month period ended 31 March 2023.

 

Highlights

Financial

·

Revenue of £2.9m (H1 FY22: £2.7m), a 9% increase over H1 FY22

·

Gross profit of £1.3m (H1 FY22: £1.1m)

·

Gross margin improved to 47% (H1 FY22: 41%)

·

EBITDA breakeven achieved (H1 FY22: £0.2m EBITDA loss)

·

Available cash resources at 31 March 2023 were £0.7m (30 September 2022: £0.7m)

·

Selling price increases successful in mitigating input cost inflation

·

Profit and working capital improvement actions announced in December 2022 are running ahead of expectations and are now expected to yield £0.5m of benefit for the full financial year

Commercial

· Energy (representing 64% of H1 FY23 sales): total energy sales increased by 29%

· Industrial (representing 33% of H1 FY23 sales): revenue fell 17% mainly due to the timing of orders

· Aerospace (representing 3% of H1 FY23 sales): sales to the aerospace sector increased by 10% as production orders are now regularly being received

 

Commenting on the results, Philip Kirkham, CEO of Hardide plc, said:

"The Group performed well in the first half, with revenues up 9% from H1 FY22 and 22% higher than H2 FY22. This reflected improving market conditions in the oil & gas sector, new project wins and the recovery of input cost inflation in selling prices. We were pleased to deliver an EBITDA breakeven performance for the period, bringing us closer to achieving our strategic milestone of becoming EBITDA and operating cash flow positive.

"The Board expects the positive sales growth to continue into the second half year. Therefore, whilst mindful of ongoing external economic uncertainties and headwinds, including further cost inflation, the Board anticipates performance for the full financial year to be in line with its expectations.

"More broadly, the Board believes that the Group will continue to benefit from significant growth potential over the short, medium and longer term from increasing market adoption of our unique patented coatings technology, which helps customers to improve operational efficiency, lower life cycle costs and reduce their carbon footprint."

Enquiries:

Hardide plc

Philip Kirkham, CEO

Jackie Heddle, Communications Manager

 

Tel: +44 (0) 1869 353 830

 

IFC Advisory

Graham Herring

Tim Metcalfe

Florence Chandler

 

Tel: +44 (0) 20 3934 6630

 

finnCap - Nominated Adviser and Joint Broker

Henrik Persson/ Abigail Kelly (Corporate Finance)

Barney Hayward (ECM/Broking)

 

Tel: +44 (0) 2072 200 500

 

Allenby Capital - Joint Broker

Tony Quirke/ Joscelin Pinnington - Sales and Corporate Broking

Jeremy Porter/ Dan Dearden-Williams - Corporate Finance

 

 

Tel: +44 (0) 20 3328 5656

Notes to editors:

www.hardide.com

 

Hardide develops, manufactures and applies advanced technology tungsten carbide/tungsten metal matrix coatings to a wide range of engineering components. Its patented technology is unique in combining in one material, a mix of toughness and resistance to abrasion, erosion and corrosion; together with the ability to coat accurately interior surfaces and complex geometries. The material is proven to offer dramatic improvements in component life, particularly when applied to components that operate in very aggressive environments. This results in cost savings through reduced downtime and increased operational efficiency as well as a reduced carbon footprint. Customers include leading companies operating in the energy sectors, valve and pump manufacturing, industrial gas turbine, precision engineering and aerospace industries.

 

OVERVIEW

I am pleased to report that good progress is being made towards achieving the strategic milestone of the Group becoming EBITDA and operating cash flow positive.

Revenues in H1 FY23 grew by 9% to £2.9m (H1 FY22: £2.7m). The growth rate was softened by the delay of an expected large project order for the coating of turbine blades. This is now expected later in this calendar year. Revenue in H1 FY22 had benefited from an order of similar value; and excluding that order from H1 FY22 sales, H1 FY23 revenues would be 21% ahead of H1 FY22.

The increase in revenues allowed the Group to improve capacity utilisation and better leverage fixed costs which, together with good recovery of input cost inflation in selling prices, enabled a significant improvement in gross margin to 47% (H1 FY22: 41%).

The combination of revenue growth and higher gross margin enabled us to deliver an EBITDA breakeven performance for the period (H1 FY22: EBITDA loss of £0.2m).

EBITDA benefited from a net non-recurring property gain of £0.1m described further below. EBITDA in H1 FY22 benefited from £0.2m of Covid support.

The Group balanced its cash flows overall for the period, with £0.7m of available cash resources on the balance sheet at 31 March 2023 (30 September 2022: £0.7m). The cash balance has been relatively stable in recent months, reflecting the EBITDA breakeven performance. The Group is well invested and, in general, has sufficient operational capacity to support approximately double the current annualised revenue, depending on product mix, over the short to medium term without further major capital investment. Nonetheless, the Board continues to explore opportunities to further strengthen the balance sheet to build additional headroom and resilience.

The Group is making strong progress in commercialising new applications that have been subject to long and/or delayed test and development programmes. It is pleasing to note several first new orders, resulting from these programmes, from customers in the power generation, oil & gas drilling and aerospace sectors.

Revenue growth is expected to continue into the second half year, and performance for the full financial year is expected to be in line with the Board's expectations.

STRATEGIC DEVELOPMENT

The Group is on track to achieve its initial strategic objective of becoming consistently EBITDA and operating cash flow positive, enabling us then to drive towards full profitability.

Good progress is being made on technical co-operation with other large coatings companies to develop mutually beneficial commercial opportunities; technical and co-operation agreements have been signed with two global companies.

COMMERCIAL AND OPERATIONAL OVERVIEW

 

Customers and Markets

 

In H1 FY23, end use market segmentation was:

·

Energy (including oil & gas, power generation and alternative energy): 64% (H1 FY22: 54%)

·

Industrial: 33% (H1 FY22: 43%)

·

Aerospace: 3% (H1 FY22: 3%)

 

Energy

Sales to energy customers increased by 29%.

Recovery from the oil & gas sector was strong with revenue increasing by 54% compared with H1 FY22. Nonetheless, recovery has been slower than expected due to ongoing material supply and labour shortages in the oil & gas supply chain. Indications from customers are that the situation is improving. We expect revenue growth from this sector to continue in H2 FY23. The first major order was received from a new customer for well stimulation components, and successful trials and developments are underway with customers in sand control systems, downhole drilling tools and other oil & gas components.

The delayed order from the existing power generation customer is now expected later in calendar year 2023. Following extensive testing, it is expected that our first order will be received in H2 FY23 from the second largest global industrial gas turbine (IGT) producer, for sets of gas turbine vanes. The coating is also in trials for coated blades and vanes with other large IGT manufacturers.

 

Testing of the coating for both EV battery and hydrogen applications continues to progress and all tests have been successful and productive. Customer testing by a major European company in the hydrogen production and distribution sector is underway. The Henry-Royce Institute's grant-supported project with Cranfield University to investigate 'green' hydrogen production produced very promising results. Further grant applications are being made to take the project to the next stage.

 

Industrial

Revenue from our industrial customers fell by 17% primarily due to phasing of demand. We expect this revenue to recover this in the second half of the year.

Aerospace

Sales revenue from aerospace customers increased by 10%. Momentum is building as production orders are now being received regularly for the coating of wing components for the Airbus A320, A330, A380 and A400M aircraft with other parts for these aircraft currently in test. Of particular significance is a new approval received for high volume components for the Airbus A320 where the Hardide coating is replacing a competitor's coating. Orders are due to commence in H2 FY23. Further orders were received for parts for Lockheed Martin's F35 Joint Strike Fighter. Following Leonardo Helicopters' approval, orders are now being received for the coating of transmission system components.

Profit and cash improvement plan

In December 2022 we announced an initiative to improve profit and cash flow by £0.3-0.4m by summer 2023. We are pleased to report that this initiative is now anticipated to exceed initial expectations and bring an overall benefit of c.£0.5m for the full financial year, comprising:

·  Cost savings of £0.2m

·  Grants to offset development and testing costs of £0.1m

·  Selling price increase / cost inflation recovery of £0.1m

·  Working capital improvements of £0.1m.

 

FINANCIAL REVIEW

 

Income statement

Revenues for H1 FY23 were £2.9m, an increase of 9% from H1 FY22 and 22% higher than the prior half year of H2 FY22. This reflects improving market demand, particularly in the oil and gas sector, increasing customer adoption of our unique coatings technology, and price increases to offset input cost inflation.

This revenue growth enabled us to improve capacity utilisation and better leverage fixed costs, driving a 6 percentage point increase in gross margin to 47% (H1 FY22: 41%). Together with good control of overheads, the increase in revenues and improvement in gross margin enabled us to deliver an EBITDA breakeven performance for the period (H1 FY22: £0.2m EBITDA loss).

The EBITDA breakeven result benefited from a net £0.1m non-recurring gain relating mainly to the purchase, sale and leaseback of our facility in Martinsville, USA, in December 2022. The EBITDA loss in H1 FY22 benefited from £0.2m of COVID-19 US Government support.

There were no significant changes in depreciation or financing costs compared to previous periods. The loss before taxation was £0.6m (H1 22: loss of £0.8m).

Cash Flow, Going Concern and Financing

Overall, the Group balanced its cash flows in H1 FY23, with available cash resources at both the beginning and end of the period of £0.7m. Excluding the one-off cash flow benefit of £0.5m from the new Martinsville leasing arrangements and adjusting for period-end timing differences relating to supplier payments, the underlying net cash outflow in the half year was circa £0.2m.

The Group's cash balance has been reasonably stable for the last few months. This illustrates, alongside the EBITDA breakeven result, that the Group is now very close to achieving its key strategic milestone of becoming operating cash flow self-sufficient. The Group is very well invested, has sufficient spare operational capacity to support significant revenue growth and therefore we do not currently anticipate any need for further large amounts of capital expenditure.

Gross debt at 31 March 2023, comprising Coronavirus Business Interruption Loan Schemes ("CBILS") and asset finance arrangements, but excluding lease obligations reported under IFRS 16, was £1.0m (H1 FY22: £1.2m). Of the amount outstanding at 31 March 2022, £0.3m is repayable within one year. Net debt at both 31 March 2023 and 2022 was £0.3m.

Lease obligations reported under IFRS 16 at 31 March 2023 were £2.3m (31 March 2022: £2.0m), the increase being due to the new 10-year property lease agreement entered into in Martinsville in December 2022.

Therefore, having reviewed cash flow forecasts and associated sensitivity analysis, the Board has concluded that the Group has sufficient financial resources to meet its needs for the foreseeable future and accordingly has prepared the interim financial statements on a going concern basis. 

RISK REVIEW

The Board confirms that the risk assessment disclosed in our 2022 annual report remains relevant for the remainder of the current financial year. The risks and uncertainties relating to macroeconomic and geopolitical factors, and the precise timing of customer orders on revenue realisation are those currently judged by the Board as being the most relevant to delivery of current financial year performance expectations.

BUSINESS DEVELOPMENT

Our operational capacity is sufficient to produce a sales revenue of approximately £10m (depending on product mix). With average current utilisation of this capacity running at around 60%, there are adequate resources available to achieve our aim of maximising utilisation of this spare capacity over the next few years. We aim to do this by new developments including c. £1m in the oil & gas sector, more than £1m in power generation and up to £1m in aerospace. We should achieve EPS positive results at approximately £7.5m-£8.0m revenue.

OUTLOOK

The Board expects the positive sales growth seen in H1 FY23 to continue in H2 FY23. Therefore, whilst mindful of ongoing external economic uncertainties and headwinds, including further cost inflation, the Board anticipates performance for the full financial year to be in line with its expectations.

More broadly, the Board believes that the Group should continue to benefit from significant growth potential over the short, medium and longer term from increasing market adoption of our unique patented coatings technology, which helps customers to improve operational efficiency, lower life cycle costs and reduce their carbon footprint.

 

Philip Kirkham

Chief Executive Officer

17 May 2023

 

 

 

Income Statement

 

£ 000

 

 

6 months to

31 March 2023

(unaudited)

 

6 months to

31 March 2022

(unaudited)

Year to

30 September 2022

(audited)

 

Revenue

2,886

2,658

5,015

Cost of Sales

(1,539)

(1,556)

(3,135)

Gross profit

1,347

1,102

1,880

Administrative expenses

(1,338)

(1,323)

(2,821)

Depreciation - owned assets

(440)

(433)

(890)

Depreciation - right of use assets

(98)

(64)

(318)

Operating loss

(529)

(718)

(2,149)

Finance income

1

1

4

Finance costs

(32)

(14)

(49)

Finance costs on right of use assets

(48)

(40)

(80)

Loss on ordinary activities before tax

(608)

(771)

(2,274)

Tax

(6)

15

86

Loss on ordinary activities after tax

(614)

(756)

(2,188)

 

 

 

Consolidated Statement of Changes in Equity

 

£ 000

 

 

6 months to

31 March 2023

(unaudited)

 

6 months to

31 March 2022

(unaudited)

Year to

30 September 2022

(audited)

 

Total equity at start of period

5,530

6,914

6,914

 

 

Loss for the period

(614)

(756)

(2,188)

Issue of new shares

-

-

509

Exchange differences on translation of foreign operation

(94)

38

304

Share options

-

-

(9)

 

 

Total equity at end of period

4,822

6,196

5,530

 

 

Consolidated Statement of Financial Position

 

£ 000

 

 

31 March 2023

(unaudited)

 

31 March 2022

(unaudited)

30 September 2022

(audited)

 

 

 

Assets

 

 

Non-current assets

 

Goodwill

69

69

69

 

Intangible assets

13

27

19

 

Property, plant & equipment

4,837

5,490

5,402

 

Right of Use Assets

1,813

1,821

1,660

 

Total non-current assets

6,732

7,407

7,150

 

 

 

Current assets

 

 

Inventories

214

362

487

 

Trade and other receivables

1,013

1,146

955

 

Other current financial assets

232

357

450

 

Cash and cash equivalents

701

864

693

 

Total current assets

2,160

2,729

2,585

 

 

 

Total assets

8,892

10,136

9,735

 

 

 

Liabilities

 

 

 

 

Current liabilities

 

 

Trade and other payables

710

665

1,077

 

Financial liabilities - loans and deferred income

256

258

257

 

Financial liabilities - leases

171

199

201

 

Provision for dilapidations

-

12

-

 

Total current liabilities

1,137

1,134

1,535

 

 

 

Net current assets

1,023

1,595

1,050

 

 

 

Non-current liabilities

 

 

Financial liabilities - loans and deferred income

708

941

878

 

Financial liabilities - leases

2,175

1,815

1,742

 

Provision for dilapidations

50

50

50

 

Total non-current liabilities

2,933

2,806

2,670

 

 

 

Total liabilities

4,070

3,940

4,205

 

 

 

Net assets

4,822

6,196

5,530

 

 

 

Equity attributable to equity holders of the parent

 

 

Share capital

4,063

3,942

4,063

 

Share premium

19,242

18,854

19,242

 

Retained earnings

(18,814)

(16,766)

(18,200)

 

Share-based payment reserve

553

562

553

 

Translation reserve

(222)

(396)

(128)

 

Total equity

4,822

6,196

5,530

 

 

Consolidated Statement of Cash Flows

 

£ 000

 

 

6 months to

31 March 2023

(unaudited)

 

6 months to

31 March 2022

(unaudited)

Year to

30 September 2022

(audited)

 

Cash flows from operating activities

 

Operating (loss)

(529)

(718)

(2,149)

 

Depreciation - owned assets

440

433

890

 

Depreciation - right of use assets

98

64

318

 

Gain on sale and leaseback

(157)

-

-

 

Share option charge

-

-

(9)

 

Decrease in inventories

273

142

17

 

Decrease / (increase) in receivables

73

(544)

(372)

 

(Decrease) / increase in payables

(286)

(42)

372

 

(Decrease) in provisions

-

(22)

(34)

 

 

Cash generated from operations

(88)

(687)

(967)

 

 

Finance income

1

1

4

 

Finance costs

(32)

(14)

(49)

 

Interest on right of use assets

(48)

(40)

(80)

 

Tax received

82

80

78

 

 

 

Net cash generated from operating activities

(85)

(660)

(1,014)

 

 

Cash flows from investing activities

 

Proceeds from sale and leaseback

477

-

-

 

Proceeds from sales of property, plant, equipment

Purchase of intangibles

Purchase of property, plant, equipment

 

-

-

(105)

 

-

-

(185)

 

7

(1)

(298)

 

 

Net cash used in investing activities

182

(185)

(292)

 

 

Cash flows from financing activities

 

Net proceeds from issue of ordinary share capital

-

-

509

 

Loans raised

-

333

325

 

Loans repaid

(147)

(75)

(261)

 

Lease principal repayments

(135)

(98)

(251)

 

Net cash used in financing activities

(282)

160

322

 

Effect of exchange rate fluctuations

3

6

134

 

Net decrease in cash and cash equivalents

8

(679)

(850)

 

 

Cash and cash equivalents at the beginning of the period

693

1,543

1,543

 

 

Cash and cash equivalents at the end of the period

701

864

693

 

 

 

Notes

 

1. Basis of preparation of financial information

While the financial information included in these interim financial results for the half year ended 31 March 2023 have been prepared in accordance with the recognition and measurement principles of international accounting standards in conformity with the requirements of Companies Act 2006, this announcement does not contain sufficient information to comply with IFRS's.

These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements for the year ended 30 September 2022, which have been prepared in accordance with UK adopted international accounting standards and with the requirements of the Companies Act 2006 as applicable to companies reporting under these standards.

The financial information set out above does not constitute the Company's statutory accounts as defined by section 434 of the UK Companies Act 2006. A copy of the statutory accounts for Hardide plc for the year ended 30 September 2022 has been delivered to the Registrar of Companies. The auditors have reported on those accounts; their reports were unqualified and did not include references to any matters to which the auditors drew attention by way of emphasis without qualifying their reports. Their reports for the year ended 30 September 2022 did not contain statements under section 498 (2) or (3) of the Companies Act 2006.

The consolidated financial statements present the results of the Company and its subsidiaries ("the Group") as if they formed a single entity. Intercompany transactions and balances between Group companies are therefore eliminated in full. Subsidiaries are fully consolidated from the date on which control is transferred to the Group and cease to be consolidated from the date on which control is transferred out of the Group.

2. Segmental information

Under IFRS8, operating segments are defined as a component of the entity (a) that engages in business activities from which it may earn revenues and incur expenses (b) whose operating results are regularly reviewed and (c) for which discrete financial information is available. The Group management is organised in to UK and USA operation and Corporate central functions, and this factor identifies the Group's reportable segments.

 

6 months ended

31 March 2023 

UK operation £000

US operation

£000

Corporate

£000

Total

£000

 

 

1,518

 

1,368

 

-

 

2,886

External revenue

 

 

 

 

Reportable segment profit / (loss)

(395)

442

(661)

(614)

 

 

 

 

 

Segment assets

 

6,466

 

2,299

 

127

 

8,892

 

 

 

 

Segment liabilities

 

2,522

 

1,216

 

332

 

4,070

 

 

6 months ended

31 March 2022

UK operation £000

US operation

£000

Corporate

£000

Total

£000

 

 

1,532

 

1,126

 

-

 

2,658

 

External revenue

Reportable segment profit / (loss)

(475)

319

(600)

(756)

 

 

 

 

 

Segment assets

 

7,119

 

2,724

 

293

 

10,136

 

 

 

 

Segment liabilities

 

2,897

 

707

 

336

 

3,940

 

 

 

12 months ended

30 September 2022 

UK operation £000

US operation

£000

Corporate

£000

Total

£000

 

 

3,076

 

1,939

 

-

 

5,015

External revenue

 

 

 

 

Reportable segment profit / (loss)

(1,650)

186

(724)

(2,188)

 

 

 

 

 

Segment assets

6,855

2,323

557

9,735

Segment liabilities

2,962

893

350

4,205

 

 

The Group currently has a single business product, so no secondary analysis is presented. Revenue from external customers is attributed according to their country of domicile. Turnover by geographical destination is as follows:

 

External sales

UK

£000

Europe

£000

N America

£000

Rest of World

£000

Total

£000

 

 

 

 

31 March 2023

767

79

2,023

17

2,886

31 March 2022

646

267

1,744

1

2,658

30 September 2022

1,314

666

3,007

28

5,015

 

 

3. Earnings per share

31 March 2023

£000

 

31 March 2022£000

30 September 2022

£000

(Loss) on ordinary activities after tax

(614)

(756)

(2,188)

 

Basic earnings per ordinary share:

 

 

Weighted average number of ordinary shares in issue

58,901,959

55,875,645

56,058,053

Earnings per share

(1.0)p

(1.4)p

(3.9)p

 

As net losses were recorded in each of the respective periods, the potentially dilutive share options are anti-dilutive for the purposes of the loss per share calculation and their effect is therefore not considered.

 

4. Going concern

The directors have adopted the going concern basis in preparing the interim financial statements after assessing the principal risks and having considered the impact of various downside scenarios compared to the Group's base case financial plans, the pace of sales growth and the level of profit margins for a period of at least 12 months from the date of releasing the interim results. Whilst the macro-economic position continues to be uncertain, the directors have considered various impacts on sales, profitability and cash flows and believe that the Group will have adequate resources to continue in operational existence for the foreseeable future.

 

5. Debt maturity

Loans

31 March2023£000

31 March2022

£000

 

30 September 2022

£000

Total loans

 

868

1,092

1,018

 

Maturity analysis:

 

Within 1 year

239

242

238

1 to 2 years

251

236

250

2 to 3 years

170

248

217

3 to 4 years

105

167

149

4 to 5 years

55

102

81

5+ years

48

97

83

 

 

Deferred income

31 March2023£000

31 March2022

£000

 

30 September 2022

£000

Total deferred income

 

96

107

117

 

Maturity analysis:

 

Within 1 year

17

16

19

1 to 2 years

17

16

19

2 to 3 years

17

16

19

3 to 4 years

17

16

19

4 to 5 years

17

16

19

5+ years

11

27

22

 

 

Right of use lease liabilities

31 March2023£000

31 March2022

£000

 

30 September 2022

£000

Total lease liabilities

 

2,346

2,014

1,943

 

Maturity analysis:

 

Within 1 year

171

199

201

1 to 2 years

180

182

196

2 to 3 years

187

190

174

3 to 4 years

195

138

133

4 to 5 years

202

136

139

5+ years

1,411

1,169

1,100

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR KZGMKKVRGFZM
Date   Source Headline
18th Apr 20245:40 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSLaunch of Ready Coated Component Range
25th Mar 20241:06 pmRNSResult of AGM
25th Mar 20247:00 amRNSAGM Statement
12th Mar 20242:57 pmRNSHolding(s) in Company
6th Mar 20245:10 pmRNSHolding(s) in Company
5th Mar 20243:02 pmRNSBoard Update
5th Mar 20241:33 pmRNSHolding(s) in Company
5th Mar 202410:30 amRNSHolding(s) in Company
26th Feb 20242:04 pmRNSHolding(s) in Company
23rd Feb 202412:33 pmRNSHolding(s) in Company
21st Feb 20246:00 pmRNSResult of Fundraising
21st Feb 20244:35 pmRNSProposed equity fundraising
21st Feb 20244:30 pmRNSAudited Annual Report and Notice of AGM
8th Feb 20247:00 amRNSInterim CEO appointment
8th Feb 20247:00 amRNSPreliminary FY23 results & FY24 trading update
1st Nov 20237:00 amRNSBoard Changes
18th Oct 20237:00 amRNSYear End Trading Update
21st Jul 20239:02 amRNSHolding(s) in Company
26th May 20231:46 pmRNSDirector/PDMR Shareholding
17th May 20237:00 amRNSInterim Results
10th May 20237:00 amRNSHardide Coatings partners with Gardner Aerospace
23rd Mar 202312:18 pmRNSHolding(s) in Company
23rd Mar 202311:36 amRNSResult of AGM
23rd Mar 20237:00 amRNSAGM Statement
22nd Feb 20234:33 pmRNSPosting of Annual Report and Notice of AGM
8th Feb 20237:00 amRNSAnnual results for year ended 30 September 2022
25th Jan 20237:00 amRNSBoard Update
22nd Dec 20227:00 amRNSFunding and Annual Results Update
15th Nov 20228:16 amRNSHolding(s) in Company
27th Oct 20227:00 amRNSSupplier Approval & Order for Leonardo Helicopters
24th Oct 20223:00 pmRNSDirectorate Changes
13th Oct 20227:00 amRNSYear End Trading Update
9th Sep 202211:45 amRNSResult of Fundraising
9th Sep 20227:00 amRNSProposed equity fundraising
14th Jul 20227:00 amRNSTrading update
10th May 20227:00 amRNSResignation of Non-Executive Chairman
10th May 20227:00 amRNSInterim Results
5th Apr 20221:53 pmRNSHolding(s) in Company
22nd Mar 20228:37 amRNSHolding(s) in Company
11th Mar 202212:37 pmRNSResult of AGM
11th Mar 20227:00 amRNSAGM Statement
1st Mar 20227:00 amRNSContract Award
15th Feb 20224:15 pmRNSPosting of Annual Report and Notice of AGM
6th Dec 20217:00 amRNSPreliminary results
19th Oct 20217:00 amRNSHolding(s) in Company
7th Oct 20219:05 amRNSSecond Price Monitoring Extn
7th Oct 20219:00 amRNSPrice Monitoring Extension
7th Oct 20217:00 amRNSYear End Trading Update
9th Sep 20212:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.